These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 19787152)
61. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Farrell PM; Kosorok MR; Rock MJ; Laxova A; Zeng L; Lai HC; Hoffman G; Laessig RH; Splaingard ML Pediatrics; 2001 Jan; 107(1):1-13. PubMed ID: 11134427 [TBL] [Abstract][Full Text] [Related]
62. One-year evaluation of a neonatal screening program for cystic fibrosis in Switzerland. Rueegg CS; Kuehni CE; Gallati S; Baumgartner M; Torresani T; Barben J; Dtsch Arztebl Int; 2013 May; 110(20):356-63. PubMed ID: 23825488 [TBL] [Abstract][Full Text] [Related]
63. Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening. Sontag MK; Corey M; Hokanson JE; Marshall JA; Sommer SS; Zerbe GO; Accurso FJ J Pediatr; 2006 Nov; 149(5):650-657. PubMed ID: 17095337 [TBL] [Abstract][Full Text] [Related]
64. An Enzyme Immunoassay for Determining Immunoreactive Trypsinogen (IRT) in Dried Blood Spots on Filter Paper Using an Ultra-Microanalytical System. Castells Martínez EM; González EC; Tejeda Y; Frómeta A; Martín O; Espinosa M; Del Río L; Pérez PL; Morejón G; Perea Y; Melchor A Appl Biochem Biotechnol; 2018 Dec; 186(4):1034-1046. PubMed ID: 29808455 [TBL] [Abstract][Full Text] [Related]
65. Implementation of the French nationwide cystic fibrosis newborn screening program. Munck A; Dhondt JL; Sahler C; Roussey M J Pediatr; 2008 Aug; 153(2):228-33, 233.e1. PubMed ID: 18534227 [TBL] [Abstract][Full Text] [Related]
66. Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen. Kloosterboer M; Hoffman G; Rock M; Gershan W; Laxova A; Li Z; Farrell PM Pediatrics; 2009 Feb; 123(2):e338-46. PubMed ID: 19171585 [TBL] [Abstract][Full Text] [Related]
67. Neonatal screening for cystic fibrosis: comparing the performances of IRT/DNA and IRT/PAP. Sarles J; Giorgi R; Berthézène P; Munck A; Cheillan D; Dagorn JC; Roussey M J Cyst Fibros; 2014 Jul; 13(4):384-90. PubMed ID: 24513262 [TBL] [Abstract][Full Text] [Related]
68. Newborn screening for cystic fibrosis: can one algorithm fit all? Caggana M Expert Rev Mol Diagn; 2017 Mar; 17(3):205-207. PubMed ID: 28127999 [No Abstract] [Full Text] [Related]
69. [Newborn Screening on Cystic Fibrosis in Germany: Comparison of the new Screening Protocol with an Alternative Protocol]. Sommerburg O; Stahl M; Hammermann J; Okun JG; Kulozik A; Hoffmann G; Mall M Klin Padiatr; 2017 Mar; 229(2):59-66. PubMed ID: 28444650 [No Abstract] [Full Text] [Related]
71. Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots. Crossley JR; Smith PA; Edgar BW; Gluckman PD; Elliott RB Clin Chim Acta; 1981 Jun; 113(2):111-21. PubMed ID: 7249357 [TBL] [Abstract][Full Text] [Related]
72. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening. Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149 [TBL] [Abstract][Full Text] [Related]
73. [Mucoviscidosis screening of newborn infants in the Dresden district. Results from 1 June 1996 to 31 March 2000]. Wunderlich P; Stopsack M; Paul KD; Rösen-Wolff A Dtsch Med Wochenschr; 2000 Nov; 125(45):1356-60. PubMed ID: 11109423 [TBL] [Abstract][Full Text] [Related]
74. [The French nationwide cystic fibrosis newborn screening program: strategy and results]. Munck A; Roussey M Arch Pediatr; 2008 Jun; 15 Suppl 1():S1-6. PubMed ID: 18822253 [TBL] [Abstract][Full Text] [Related]
75. Newborn screening for cystic fibrosis by use of a multiplex immunoassay. Lindau-Shepard BA; Pass KA Clin Chem; 2010 Mar; 56(3):445-50. PubMed ID: 20040620 [TBL] [Abstract][Full Text] [Related]
76. Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data. van der Ploeg CP; van den Akker-van Marle ME; Vernooij-van Langen AM; Elvers LH; Gille JJ; Verkerk PH; Dankert-Roelse JE; J Cyst Fibros; 2015 Mar; 14(2):194-202. PubMed ID: 25213034 [TBL] [Abstract][Full Text] [Related]
77. Cystic fibrosis newborn screening: shifting the key question from "should we screen?" to "how should we screen?". Farrell PM Pediatrics; 2004 Jun; 113(6):1811-2. PubMed ID: 15173512 [No Abstract] [Full Text] [Related]
78. Elevated IRT levels in African-American infants: implications for newborn screening in an ethnically diverse population. Giusti R; Pediatr Pulmonol; 2008 Jul; 43(7):638-41. PubMed ID: 18500736 [TBL] [Abstract][Full Text] [Related]
80. Screening for cystic fibrosis: a four year regional experience. Roberts G; Stanfield M; Black A; Redmond A Arch Dis Child; 1988 Dec; 63(12):1438-43. PubMed ID: 3232990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]